<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>48(2)</volume><submitter>Kortl T</submitter><funding>This study was supported by research grants awarded to Samuel Sossalla by the Deutsche Forschungsgemeinschaft (DFG) (SO 1223/4-1) and the F. Thyssen Foundation (Az 10.19.2.026MN).</funding><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Arrhythmia-induced cardiomyopathy (AIC) is an underrecognized condition resulting in left ventricular systolic dysfunction (LVSD) that is primarily caused by atrial fibrillation (AFib). The relationship between AIC, right ventricular (RV) function, and quality of life (QoL) has not been well studied.&lt;h4>Methods&lt;/h4>We performed a post-hoc analysis of our AIC trial in which we prospectively screened for patients with tachyarrhythmia and newly diagnosed, otherwise unexplained LVSD. Following rhythm restoration, patients were followed up at 2, 4, and 6 months. Only patients with persistent sinus rhythm were analyzed. RV function was assessed via echocardiography (tricuspid annular plane systolic excursion [TASPE] and fractional area change [FAC]) and QoL by the Minnesota </pubmed_abstract><journal>Clinical cardiology</journal><pagination>e70070</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11845871</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Right Ventricular Systolic Dysfunction Predicts Recovery of Left Ventricular Systolic Function and Reduced Quality of Life in Patients With Arrhythmia-Induced Cardiomyopathy.</pubmed_title><pmcid>PMC11845871</pmcid><pubmed_authors>Kortl T</pubmed_authors><pubmed_authors>Meindl C</pubmed_authors><pubmed_authors>Maier LS</pubmed_authors><pubmed_authors>Wachter R</pubmed_authors><pubmed_authors>Sossalla S</pubmed_authors><pubmed_authors>Schach C</pubmed_authors><pubmed_authors>Muhleck F</pubmed_authors><pubmed_authors>Resch M</pubmed_authors><pubmed_authors>Baum P</pubmed_authors><pubmed_authors>Ucer E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Right Ventricular Systolic Dysfunction Predicts Recovery of Left Ventricular Systolic Function and Reduced Quality of Life in Patients With Arrhythmia-Induced Cardiomyopathy.</name><description>&lt;h4>Introduction&lt;/h4>Arrhythmia-induced cardiomyopathy (AIC) is an underrecognized condition resulting in left ventricular systolic dysfunction (LVSD) that is primarily caused by atrial fibrillation (AFib). The relationship between AIC, right ventricular (RV) function, and quality of life (QoL) has not been well studied.&lt;h4>Methods&lt;/h4>We performed a post-hoc analysis of our AIC trial in which we prospectively screened for patients with tachyarrhythmia and newly diagnosed, otherwise unexplained LVSD. Following rhythm restoration, patients were followed up at 2, 4, and 6 months. Only patients with persistent sinus rhythm were analyzed. RV function was assessed via echocardiography (tricuspid annular plane systolic excursion [TASPE] and fractional area change [FAC]) and QoL by the Minnesota </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2025-04-04T01:19:48.676Z</modification><creation>2025-04-04T01:19:48.676Z</creation></dates><accession>S-EPMC11845871</accession><cross_references><pubmed>39985307</pubmed><doi>10.1002/clc.70070</doi></cross_references></HashMap>